SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-062938
Filing Date
2009-11-16
Accepted
2009-11-16 14:40:21
Documents
6
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. b77242e10vq.htm 10-Q 278905
2 EX-10.3 SECURITIES PURCHASE AGREEMENT DATED AUGUST 11, 2009 b77242exv10w3.htm EX-10.3 74533
3 EX-31.1 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b77242exv31w1.htm EX-31.1 8311
4 EX-31.2 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER b77242exv31w2.htm EX-31.2 8393
5 EX-32.1 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b77242exv32w1.htm EX-32.1 2998
6 EX-32.2 SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER b77242exv32w2.htm EX-32.2 2836
  Complete submission text file 0000950123-09-062938.txt   377688
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 091185902
SIC: 2834 Pharmaceutical Preparations